SCHEMBL6973330

SCHEMBL6973330

Nc1nc(O)c2sc(=O)n(Cc3ccccc3)c2n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.43
PKM P14618 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
ADORA2A P29274 4/20 0.43
GSK3A P49840 2/20 0.43
GSK3B P49841 2/20 0.43
RAB9A P51151 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
RECQL P46063 1/20 0.40
PNP P00491 3/20 0.40
BCL2 P10415 1/20 0.39
MCL1 Q07820 1/20 0.39
TLR7 Q9NYK1 3/20 0.39
POLB P06746 1/20 0.39
MTOR P42345 1/20 0.38
MEN1 O00255 1/20 0.38
HPGD P15428 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14725008 0.87 TLR7 (0.43) KDM4EPKMADORA2AALDH1A1LMNA
SCHEMBL15292864 0.84 ALDH1A1 (0.53) KDM4EL3MBTL1ADORA2ASMN1; SMN2ALDH1A1
SCHEMBL14725005 0.83 TLR7 (0.39) TLR7MEN1KMT2A
SCHEMBL6970797 0.82 TLR7 (0.41) ADORA2ASMN1; SMN2TLR7MTOR
SCHEMBL8439184 0.76 PNP (0.61) KDM4EPKML3MBTL1GSK3AGSK3B
SCHEMBL25539344 0.75 CYP2C19 (0.33) KDM4EADORA2AALDH1A1HPGD
SCHEMBL338747 0.75 L3MBTL1 (0.51) KDM4EPKML3MBTL1ADORA2AGSK3A
SCHEMBL6974590 0.74
SCHEMBL15295610 0.74
SCHEMBL20521292 0.72 ALDH1A1 (0.36) KDM4EPKML3MBTL1ADORA2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120121541-A1 3,5-DISUBSTITUTED AND 3,5,7-TRISUBSTITUTED-3H-OXAZOLO AND 3H-THIAZOLO[4,5-D]PYRIMIDIN-2-ONE COMPOUNDS AND PRODRUGS THEREOF ANADYS PHARMACEUTICALS, INC. (US) 2012-05-17 US disclosed
US-8097718-B2 3,5-disubstituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereof ANADYS PHARMACEUTICALS, INC. (US) 2012-01-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120121541-A1 3,5-DISUBSTITUTED AND 3,5,7-TRISUBSTITUTED-3H-OXAZOLO AND 3H-THIAZOLO[4,5-D]PYRIMIDIN-2-ONE COMPOUNDS AND PRODRUGS THEREOF TLR5, THPO, IDO1 KDM4E 1730/4885PKM 2762/4885L3MBTL1 2120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.